KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Interest Coverage Ratio: 2011-2021

Historic Interest Coverage Ratio for TherapeuticsMD (TXMD) over the last 8 years, with Dec 2021 value amounting to -2.42.

  • TherapeuticsMD's Interest Coverage Ratio rose 23.99% to -287.33 in Q3 2025 from the same period last year, while for Sep 2025 it was -172.80, marking a year-over-year decrease of 205.43%. This contributed to the annual value of -2.42 for FY2021, which is 55.58% up from last year.
  • According to the latest figures from FY2021, TherapeuticsMD's Interest Coverage Ratio is -2.42, which was up 55.58% from -5.44 recorded in FY2020.
  • TherapeuticsMD's 5-year Interest Coverage Ratio high stood at -2.42 for FY2021, and its period low was -27.84 during FY2018.
  • Its 3-year average for Interest Coverage Ratio is -5.52, with a median of -5.44 in 2020.
  • Data for TherapeuticsMD's Interest Coverage Ratio shows a peak YoY skyrocketed of 68.75% (in 2019) over the last 5 years.
  • Yearly analysis of 4 years shows TherapeuticsMD's Interest Coverage Ratio stood at -27.84 in 2018, then surged by 68.75% to -8.70 in 2019, then spiked by 37.44% to -5.44 in 2020, then skyrocketed by 55.58% to -2.42 in 2021.